Alphatec Holdings Inc ATEC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
-
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
-
Securities Fraud Investigation Into Alphatec Holdings, Inc. (ATEC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
-
Alphatec Holdings, Inc. (ATEC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
-
Securities Fraud Investigation Into Alphatec Holdings, Inc. (ATEC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Trading Information
- Previous Close Price
- $8.13
- Day Range
- $7.95–8.31
- 52-Week Range
- $6.82–23.29
- Bid/Ask
- $8.01 / $8.46
- Shares Outstanding
- 153.79M
- Market Cap
- $1.27B
- Volume/Avg
- 2M / 3M
Key Statistics
- Price/Earnings (Normalized)
- 109.02
- Price/Sales
- 1.57
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 913
- Website
- https://www.atecspine.com
Valuation
|
Metric
|
ATEC
|
|---|---|
Price/Earnings (Normalized) | 109.02 |
Price/Book Value | — |
Price/Sales | 1.57 |
Price/Cash Flow | 12.99 |
Price/Earnings
ATEC
Financial Strength
|
Metric
|
ATEC
|
|---|---|
Quick Ratio | 1.03 |
Current Ratio | 1.90 |
Interest Coverage | −1.52 |
Quick Ratio
ATEC
Profitability
|
Metric
|
ATEC
|
|---|---|
Return on Assets (Normalized) | 2.09% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 9.58% |
Return on Assets
ATEC
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Sjbzzlcq | Zvqmn | $155B | |||
| Stryker Corp
SYK
| Rqrbhdyg | Bdtx | $118B | |||
| Medtronic PLC
MDT
| Zgwnhfzns | Kjblkgc | $103B | |||
| Boston Scientific Corp
BSX
| Zbvjpbwh | Ljpsjw | $70B | |||
| Edwards Lifesciences Corp
EW
| Psdnncrrm | Fvvpbrj | $49B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Ykhnmdhj | Bhd | $30B | |||
| DexCom Inc
DXCM
| Bpnjckqbc | Sxscfd | $29B | |||
| Koninklijke Philips NV ADR
PHG
| Tvd | Lvmqr | $26B | |||
| Steris PLC
STE
| Bkylzrpyv | Hgvkxp | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Fbdzhshjyj | Tgtj | $17B |